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Streptococcus agalactiae, a colonizing agent in pregnant women and the main cause of
neonatal sepsis and meningitis, has been increasingly associated with invasive disease
in nonpregnant adults. We collected a total of 87 non-repetitive S. agalactiae isolates
causing community-acquired (CA) and hospital-acquired (HA) infections in nonpregnant
adults from a teaching hospital in Shanghai between 2009 and 2013. We identified
and characterized their antibiotic resistance, sequence type (ST), serotype, virulence,
and biofilm formation. The most frequent STs were ST19 (29.9%), ST23 (16.1%), ST12
(13.8%), and ST1 (12.6%). ST19 had significantly different distributions between CA- and
HA-group B Streptococci (GBS) isolates. The most frequent serotypes were III (32.2%),
Ia (26.4%), V (14.9%), Ib (13.8%), and II (5.7%). Serotype III/ST19 was significantly
associated with levofloxacin resistance in all isoates. The HA-GBS multidrug resistant
rate was much higher than that of CA-GBS. Virulence genes pavA, cfb were found in all
isolates. Strong correlations exist between serotype Ib (CA and HA) and surface protein
genes spb1 and bac, serotype III (HA) and surface protein gene cps and GBS pilus
cluster. The serotype, epidemic clone, PFGE-based genotype, and virulence gene are
closely related between CA-GBS and HA-GBS, and certain serotypes and clone types
were significantly associated with antibiotic resistance. However, CA-GBS and HA-GBS
still had significant differences in their distribution of clone types, antibiotic resistance,
and specific virulence genes, which may provide a basis for infection control.
Keywords: Streptococcus agalactiae, antimicrobial susceptibility testing, serotype, multilocus sequence type
(MLST), pulsed-field gel electrophoresis (PFGE), virulence factor
INTRODUCTION
Streptococcus agalactiae (group B streptococcus [GBS]), a common commensal of the female genital
tract, is well established as a main cause of neonatal sepsis and meningitis and as the most
common agent of invasive infections in pregnant women (Romanik et al., 2014). Nevertheless,
in the past decade, GBS has been increasingly associated with invasive disease in nonpregnant
adults (Murayama et al., 2009). Common presentations of GBS disease in adults include skin
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and/or soft-tissue infection, bacteremia without focus,
pneumonia, urinary tract infections, and osteomyelitis; serious
clinical syndromes, such as meningitis and endocarditis, are
rare but often associated with considerable morbidity and
mortality (Al et al., 2010; Le Doare and Heath, 2013). Although
GBS infections are most frequently community-acquired (CA),
hospital-acquired (HA) disease is also of concern (Martins et al.,
2012; Le Doare and Heath, 2013).
Group B Streptococci has a variety of virulence factors that
facilitate its ability to cause disease, some of which have been
identified and characterized. Several virulence determinants are
involved in the adhesion to and invasion of host cells, as well as
in evasion from the immune system (Dutra et al., 2014). These
include capsular polysaccharides (CPSs), regulatory proteins,
surface-localized proteins, and toxins (Al et al., 2011). GBSmakes
use of a number of virulence factors, including pore-forming
toxins that damage host cells, adhesion factors that increase
binding to cells or to the extracellular matrix, evasion factors
that decrease neutrophil recruitment and prevent complement
binding, and factors that repel or otherwise induce resistance to
antimicrobial peptides (Chen et al., 2013). CPSs are recognized as
playing key roles as virulence factors and are important targets for
the development of vaccine strategies (Bellais et al., 2012; Chen
et al., 2013). GBS CPSs have chemical and antigenic differences
that enable the subdivision of this species into 10 CPS serotypes
(Ia, Ib, II, III, IV, V, VI, VII, VIII, and IX) (Beigverdi et al.,
2014; Dutra et al., 2014), dominated by five CPS types (Ia, Ib,
II, III, and V) (Stoner et al., 2015), which account for 96 and
88% of cases of invasive GBS infections in neonates and adults,
respectively (Bellais et al., 2012; Dutra et al., 2014). The available
data suggest that the serotype distribution of GBS isolates is
similar in Africa, the Western Pacific, Europe, the Americas,
and the Eastern Mediterranean regions. Therefore, conjugate
vaccines that include some or all of these serotypes hold great
promise for preventing this important disease (Le Doare and
Heath, 2013).
In recent years, the ability of GBS to form biofilms has
attracted attention for its possible role in the fitness and
virulence of this pathogen (D’Urzo et al., 2014). Interestingly,
GBS human isolates can form biofilms on both abiotic
and biotic surfaces (Rinaudo et al., 2010). Several studies
(Rinaudo et al., 2010; D’Urzo et al., 2014) have shown that
biofilm formation was a barrier that protected the pathogen
against antibiotics and human immune system pressure, and it
restricted the diffusion of antibiotics, lessening the need for the
expression of genes that would allow the cells to tolerate these
substances.
Maternal and neonatal populations are those most commonly
infected by GBS, and previous reports have generally focused
on these special populations; however, little is known about the
molecular epidemiology of the S. agalactiae isolates that cause
CA and HA infections in nonpregnant adults. Therefore, this
study was conducted to investigate and characterize the antibiotic
resistance, sequence type (ST), serotype, virulence, and biofilm
formation of GBS isolates and to compare the clinical feathers of
CA- and HA-GBS, which may provide a useful basis for infection
control.
MATERIALS AND METHODS
Clinical Definitions
CA S. agalactiae (CA-GBS) was defined as an isolate that was
obtained either from an outpatient or from an inpatient ≤48 h
after hospital admission and lacking the following risk factors:
contact with the hospital environment in the 6 months preceding
the culture, S. agalactiae infection history, residence in a long-
term care facility in the 12 months preceding the culture. HA S.
agalactiae (HA-GBS) was defined as an isolate that was obtained
from an inpatient >48 h after hospital admission or having at
least one of the risk factors decribed above (Chuang and Huang,
2013; Horcajada et al., 2013). The definition of infection followed
the guidelines published by the Centers for Disease Control and
Prevention (CDC) (Stevenson et al., 2005; Maree et al., 2007;
CDC, 2016a,b).
Ethics Statement
This study was approved by the ethics committee of Huashan
Hospital, Shanghai Medical College, Fudan University, Shanghai,
People’s Republic of China (protocol HS-H-2014-0213). All
subjects provided written informed consent before their
inclusion in the study.
Bacterial Isolates
In this study, a total of 87 unique S. agalactiae isolates causing
CA (42.5%) and HA (57.5%) infections in nonpregnant adults
(all patients were ≥18 years old) were collected from Shanghai
teaching hospital from 2009 to 2013. S. agalactiae isolates
were isolated from urine (55 isolates), respiratory samples (15
isolates), skin/soft tissue (10 isolates), vaginal fluid (5 isolates),
and drainage fluid (2 isolates). Almost 58 (66.6%) of the
isolates were from women and 29 (33.4%) were from men.
Two subpopulations were considered, the younger was aged
from 18 to 64 (73.5%), and the elderly ≥65 years old (26.5%).
Bacteria were identified as S. agalactiae by Gram staining,
colony morphology, and detection of β-hemolysis and were
further characterized using VITEK R© 2 Compact GP ID Card
(bioMérieux, Marcy l’Etoile, France). S. agalactiae isolates were
cultured in brain heart infusion medium broth (BHI) (OXOID,
Basingstoke, Britain) at 37◦C with 5% CO2, unless specified
otherwise.
Antimicrobial Susceptibility Testing
Susceptibility to penicillin G, vancomycin, erythromycin,
clindamycin, levofloxacin, cefprozi, ceftriaxone, cefotaxime,
and linezolid was measured by performing Kirby–Bauer’s
disk diffusion (OXOID, Basingstoke, Britain) according to the
Clinical and Laboratory Standard Institute (CLSI) standards
(CLSI, 2014). S. pneumoniae ATCC 49619 was used as a control
strain. Multidrug resistance (MDR) was defined as resistance
to more than any three antimicrobial agents of different classes
tested in this study (Zhang et al., 2013).
Serotyping
Streptococcus agalactiae isolates were cultured in Todd-Hewitt
liquid medium (TH; OXOID, Basingstoke, Britain). Capsular
serotyping of all isolates was carried out by a latex agglutination
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assay with a Group-B Streptococci Typing Antisera kit (Denka
Seiken, Japan) according to the manufacturer’s instructions.
Pulsed-Field Gel Electrophoresis Profiling
and Multilocus Sequence Type
Genomic DNA was extracted from bacterial culture using EZ-
10 spincolumn DNA isolation kits (Sangon, Shanghai, China)
according to the manufacturer’s instructions. Pulsed-field gel
electrophoresis (PFGE) was performed for all isolates after SmaI
macrorestriction, as previously described by Udo et al. (2013).
PFGE was used to compare the genetic diversity of the dominant
STs recovered from the same ward. Briefly, SmaI-digested DNA
embedded in agarose plugs was subjected to PFGE analysis at
14◦C in a CHEF-MAPPER system (Bio-Rad) for 20 h at 6.0
V/cm, in 0.5× Tris-borate-EDTA buffer for one stage consisting
of a 10 s initial pulse and a 45 s final pulse at a 120◦ angle.
Analysis of the digitized images was assisted by the software
BioNumerics (Applied Maths, Belgium), and each different strip
was considered to be a different PFGE type (Tenover et al.,
1995). A dendrogram was constructed by using unweighted
pair group with arithmetic averages (UPGM) according to the
similarity coefficient. PFGE-based clusters were defined as groups
of two or more isolates with a dice coefficient of ≥80% on the
dendrogram (Martins et al., 2012). Determination of multilocus
sequence type (MLST) was performed by sequencing seven
housekeeping genes (adhP, phes, atr, gInA, sdhA, glcK, and tkt),
and ST assignment was determined by analyzing the entire S.
agalactiae MLST database (http://pubmlst.org/sagalactiae) and
using goeBURST V3. Analysis of DNA sequences was performed
by using DNASTAR Seqman Pro software (DNASTAR, Inc.
Madison, USA).
Semi Quantitative Biofilm Formation Test
Biofilm formation was tested using BHI culture-treated
polystyrene 96-well flat plates according to the procedure
reported by Wang et al. (2008) with the following modifications.
After the cells were fixed in Bouin’s fixative for 1 h, the cells were
washed gently four times in phosphate-buffered saline and then
stained with 0.1% crystal violet solution. The stain was washed
off gently under slowly running water, and the plates were dried
at room temperature. The absorbance of the stained biofilm was
measured at 570 nm using a MicroELISA autoreader (Bio-Rad).
Virulence Genes
A total of 45 major GBS virulence genes (Rosenau et al., 2007;
Smith et al., 2007; Ding et al., 2009; Lin et al., 2011; Hanson
et al., 2012; Firon et al., 2013; Rato et al., 2013) were detected, and
amplification was carried out on a GeneAmp 9700 thermal cycler
(Applied Biosystems, NY, USA) under the following conditions:
an initial 5 min denaturation at 94◦C, followed by 30 cycles
of 30 s at 94◦C, 30 s at 52◦C, and 30 s at 72◦C, with a final
extension at 72◦C for 10 min (Smith et al., 2007; Lin et al., 2011).
The sequences of primers used to identify putative and known
GBS virulence genes with systematic gene names are shown in
Table S1. The PCR fragments were visualized by agarose gel
electrophoresis and ethidium bromide staining.
Typing Concordance and Statistical
Analysis
For statistical analysis, the Wallace coefficient (W) provides
a quantitative measure of the clustering concordance between
different typing methods (Pinto et al., 2008; Martins et al.,
2012). In our collection, the Wallace coefficient was calculated
to determine the concordance between PFGE-based clustering,
serotyping, STs, antimicrobial resistance and virulence gene
profiling. Simpson’s index of diversity (SID) was used to evaluate
the diversity found among the isolates studied (Carrico et al.,
2006; Martins et al., 2012). Both these calculations, as well as
the 95% confidence intervals (CI95%) were performed with
the Web tools available at http://www.comparingpartitions.info.
The Fisher exact test, as appropriate, was used to evaluate the
significance of associations. The odds ratio (OR) with 95%
Wald confidence intervals (CI95%) was calculated against all
other serotypes, STs or PFGE clusters and used to identify
particular serotypes, STs or PFGE clusters associated with certain
characteristics, controlling for a false-discovery rate (FDR) less
than or equal to 0.05 (Martins et al., 2012; Glickman et al., 2014).
RESULTS
Serotype and MLST Distribution among
PFGE Clusters
Twenty-two different STs were identified in the 87 collected GBS
isolates, the predominant STs of the isolates were identified as
ST19 (29.9%), ST23 (16.1%), ST12 (13.8%), and ST1 (12.6%).
The results of STs were summarized in Table 1, 17 different STs
were identified in CA-GBS isolates, reflecting considerable
STs diversity (SID 0.922; CI95%, 0.884 to 0.960), but only 10 STs
were identified in HA-GBS isolates, reflecting considerable STs
diversity (SID 0.789; CI95%, 0.705 to 0.872). The difference
between the distribution of ST19 in CA-GBS isolates and that in
HA-GBS isolates was statistically significant (Fisher’s exact test,
p = 0.0191). The homology of the 87 GBS strains was analyzed
using an eBURST V3 analysis (Figure 1), which identified eight
main clonal complexes (CCs) and four singleton STs that were
not identified as part of a clonal complex (Table 1). Additionally,
we also found one new STs: adhP 9, phes 5, atr 4, gInA 1, sdhA 3,
glck 3, and tkt 2.
Of the 87 total collected GBS strains, the main sertotypes were
serotypes III (32.2%), Ia (26.4%), V (14.9%), Ib (13.8%), and II
(5.7%). The results of serotyping were summarized in Table 1,
reflecting considerable overall serotype diversity (CA: SID 0.827;
CI95%, 0.790 to 0.865, HA: SID 0.757; CI95%, 0.690 to 0.824,
respectively). There was no significant difference in the serotype
distribution between CA-GBS and HA-GBS isolates (Fisher’s
exact test, all p > 0.05). These five predominant serotypes
accounted for 93% of all the tested GBS strains. However, some
of isolates were non-typeable (NT) as a result of a limitation of
the reagent. Notably, we did not find any serotype IV isolates
in our research. Interestingly, we found that the concordance
between STs and the serotype, as given by WSTs→serotype = 0.796
(CI95%, 0.669–0.923), showed that 79.6% of any pair of isolates in
the same STs also share the same serotype. The certain STs were
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FIGURE 1 | eBURST analysis of S. agalactiae using all STs available in the MLST database as of January 2016. ST nodes: green circles indicate a group
founder, yellow circles indicate a sub-group founder, red circles indicate STs isolated from community samples, and blue circles indicate STs isolated from hospital
samples.
significantly associated with particular serotypes both in CA- and
HA-GBS, namely, ST19 and serotype III, ST23 and serotype Ia,
ST12 and serotype Ib, and ST1 and serotype V (Table 1).
The isolates in this study were grouped in 16 PFGE clusters
(represented by dashed rectangles in Figure 2) according to 80%
similarity on the dendrogram, each including 2–14 strains. The
remaining isolates (n = 24) had unique profiles. The SID for
the classification of the CA and HA isolates in PFGE clusters
was 0.971 (CI95%, 0.950–0.993), and 0.943 (CI95%, 0.905–0.981),
respectively, indicating that the collection analyzed was quite
diverse and there was no significant difference in the PFGE-
based genotype distribution between CA-GBS and HA-GBS
isolates (Fisher’s exact test, all p > 0.05). The concordance
between PFGE-based genotypes and the serotype, as given by
WPFGE→serotype = 0.839 (CI95%, 0.696 to 0.982), showed that
83.9% of any pair of isolates in the same PFGE also share the
same serotype. The concordance between PFGE-based genotypes
and the eBURST-based genotypes, as given by WPFGE→sBURST
= 0.960 (CI95%, 0.943–0.976), showed that 96.0% of any pair
of isolates in the same PFGE also share the same CCs. The
certain PFGE-based genotypes were significantly associated with
particular CCs both in CA- and HA-GBS (Figure 2), showing
that cluster A, C, and D belonged to CC1, clusters E, F, G, H,
and I belonged to CC23, Clusters J, K, L, and M belonged to
CC19, Clusters N, O, and P belonged to CC10, respectively. We
observed that the identification of different GBS strains by PFGE
provides higher resolution, which could fully reflect the gene
polymorphisms in these isolates.
Antimicrobial Resistance
All tested isolates including CA- and HA-GBS were sensitive
to both penicillin and vancomycin and showed high rates
of resistance to erythromycin (69.0%) and clindamycin
(50.6%), especially CA-ST12 and HA-ST12 (100%). The overall
percentages of levofloxacin resistance was 23.5% while cefprozil,
ceftriaxone, cefotaxime, and linezolid resistance were much
lower, at 2.3, 8.0, 1.1, and 2.3%, respectively. Both CA-GBS
and HA-GBS isolates of serotype III/ST19 were significantly
associated with levofloxacin resistance. Notably, the rate
of levofloxacin resistance both in CA- and HA-GBS was
significantly higher in serotype III than in serotypes Ia, Ib, II, and
V. Moreover, HA-serotype III/ST19 showed higher resistance
rates to clindamycin than CA-serotype III/ST19. Additioanlly,
the rate of clindamycin resistance in both CA- and HA-GBS was
significantly lower in serotype Ia/ST23. Notably, no significant
differences were found in the rates of resistance to erythromycin,
clindamycin, or levofloxacin among the other STs or serotypes
(in either CA-GBS or HA-GBS). Lastly, we found that the
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FIGURE 2 | Dendrogram of the PFGE profiles of 87 GBS isolates. The dendrogram was constructed using the UPGMA method. Dice coefficients (percentages)
are indicated in the scale above the dendrogram. Each cluster (defined as a group of two or more isolates with a Dice coefficient of ≥80%) is represented in the
dendrogram.
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HA-GBS MDR rate was much higher than the MDR rate of
CA-GBS isolates (OR = 9.844; CI95%; 2.115–45.82). The overall
MDR rate for all 87 of the collected GBS isolates was 23.0%
(20/87; Table 1).
Biofilm Formation
Only 12 (13.8%) isolates produced positive results from the
biofilm formation test. Biofilm formation was not associated with
the antibiotic resistance, serotype, or clone type of either CA-GBS
or HA-GBS isolates. The erythromycin resistance rate was 83.3%
(10/12) in biofilm-positive strains, but the ability to form a
biofilm was not associated with resistance to other antibiotics,
such as erythromycin and clindamycin.
Distributional Characteristics of
Virulence-Associated Factors
Fourty-five GBS virulence genes that were related to adhesion,
invasion, or immune evasion were detected in our isolates
(Table 2). Virulence genes pavA, cfb, neuC, and pbp1A were
found in all GBS isolates, but the cpsJ gene was not found
in any of the isolates. We also found a strong correlation
of particular genes encoding virulence proteins with certain
serotypes (Table 3).
Adhesion-Related Genes
There was a significant negative association between particular
adhesion-related genes and certain serotypes (CA and/or HA),
namely, between fbsA and serotype III (CA and HA), and
between GBS pilus cluster and serotype Ia (CA and HA).
Additionally, there was also a significant positive association
between particular adhesion-related genes in the GBS pilus
cluster and certain serotypes (CA and/or HA), specifically
serotype III (HA). GBS pilus cluster genes were found in serotype
Ia (CA and HA) isolates less often than they were detected in
other serotypes (Table 3).
Invasion-Related Genes
Most β-hemolysin/cytolysin (cyl) genes could be found in all
of the isolates; however, cylK (18.4%) and spb1, hylB, and rib
could only be found in a few CA and HA isolates. There was
a significant negative association between an invasion-related
gene, spb1 and serotype Ia (CA and HA). Additionally, there
was a significant positive association between particular invasion-
related genes and certain serotypes (CA and/or HA), namely,
between cylK and serotype Ia (CA and HA), between spb1 and
serotype Ib (CA and HA), serotype V (HA), and between rib and
serotype V (CA and HA). The invasion-related genes cylA and
cylZ had significantly different distributions in the CA-GBS and
HA-GBS isolates (Table 2).
Immune Evasion-Related Genes
CpsA, cpsE, cpsG, and cpsF, all of which belong to the cps gene
cluster, could only be found in a few CA and HA isolates. There
was a significant positive association between particular immune
evasion-related genes and certain serotypes (CA and/or HA),
namely, between bac and serotype Ib (CA and HA), between
cpsIaJ and serotype Ia (CA), serotype III (CA and HA), between
TABLE 2 | Distribution of virulence genes encoding particular proteins
between CA-GBS and HA-GBS.
Category Virulence
genea
Total no. of isolates with virulence
geneb (%)
CA HA Total
Adhesion fbsA 29 (33.3) 33 (37.9) 62 (71.3)
fbsB 34 (39.1) 49 (56.3) 83 (95.4)
scpB 34 (39.1) 47 (54.0) 81 (93.1)
lmb 32 (36.8) 47 (54.0) 79 (90.8)
gbs 0628c 23 (26.4) 36 (41.4) 59 (67.8)
gbs 0629c 22 (25.3) 38 (43.7) 60 (69.0)
gbs 0630c 23 (26.4) 35 (40.2) 58 (66.7)
gbs 0631c 24 (27.6) 37 (42.5) 61 (70.1)
gbs 0632c 23 (26.4) 36 (41.4) 59 (67.8)
Invasion cylX 36 (41.4) 44 (50.6) 80 (92.0)
cylD 35 (40.2) 46 (52.9) 81 (93.1)
cylG 36 (41.4) 45 (51.7) 81 (93.1)
acpC 36 (41.4) 47 (54.0) 83 (95.4)
cylZ 37* (42.5) 43* (49.4) 80 (92.0)
cylA 37* (42.5) 42* (48.3) 79 (90.8)
cylB 37 (42.5) 47 (54.0) 84 (96.6)
cylE 36 (41.4) 44 (50.6) 80 (92.0)
cylF 34 (39.1) 45 (51.7) 79 (90.8)
cylI 37 (42.5) 49 (56.3) 86 (98.9)
cylJ 36 (41.4) 48 (55.2) 84 (96.6)
cylK 8 (9.2) 8 (9.2) 16 (18.4)
spb1 14 (16.1) 13 (14.9) 27 (31.0)
hylB 7 (8.0) 9 (10.3) 16 (18.4)
rib 4 (4.6) 3 (3.4) 7 (8.0)
bca 22 (25.3) 31 (35.6) 53 (60.9)
Immune evasion bac 11 (12.6) 10 (11.5) 21 (24.1)
cpsM 22 (25.3) 33 (37.9) 55 (63.2)
cpsIaJ 19 (21.8) 33 (37.9) 52 (59.8)
cpsI 9 (10.3) 18 (20.7) 27 (31.0)
cpsG 7 (8.0) 18 (20.7) 25 (28.7)
cpsF 4 (4.6) 10 (11.5) 14 (16.1)
cpsE 9 (10.3) 13 (14.9) 22 (25.3)
cpsD 23 (26.4) 34 (39.1) 57 (65.5)
cpsC 30 (34.5) 43 (49.4) 73 (83.9)
cpsB 28 (32.2) 38 (43.7) 66 (75.9)
cpsA 10 (11.5) 12 (13.8) 22 (25.3)
neuA 18 (20.7) 26 (29.9) 44 (50.6)
neuD 22 (25.3) 29 (33.3) 51 (58.6)
neuB 30 (34.5) 38 (43.7) 68 (78.2)
cspA 36 (41.4) 50 (57.5) 86 (98.9)
Total 37 (42.5) 50 (57.5) 87 (100.0)
aAll strains were positive for pavA, cfb, neuC, and pbp1A and were negative for cpsJ.
bBoldface indicates that there was a significantly different distributions in the CA-GBS and
HA-GBS isolates. *p < 0.05.
cGBS pilus cluster.
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TABLE 3 | Correlation between GBS particular virulence gene and serotypes across source of the infections.
Serotypes Acquired No. of isolates with particular virulence genea Total no. of
isolates
fbsA gbs 0628 gbs 0629 gbs 0630 gbs 0631 gbs 0632 cylK spb1 rib bac cpsIaJ cpsI cpsG cpsF
Ia CA 8 1** 0** 0** 1* 0*** 7*** 0** 0 0 9** 0 0 0 9
HA 14 4*** 3*** 2*** 3*** 2*** 8*** 0** 0 2 12 0 0 0 14
Ib CA 5 5 6 6 6 6 0 6** 0 6** 0 0 0 0 6
HA 5 5 5 5 5 5 0 5** 0 5** 1 0 0 0 6
II CA 4 3 3 3 3 3 0 3 0 3 0 0 0 0 4
HA 1 1 1 1 1 1 0 1 0 1 0 0 0 0 1
III CA 4* 8 7 8 8 8 0 1 0 1 9** 9*** 6** 3 9
HA 6** 17 19** 17 18** 18** 0 2 0 1 19*** 17*** 15*** 9** 19
V CA 6 5 5 5 5 5 1 4 4** 0 0 0 1 1 7
HA 5 6 6 6 6 6 0 5** 3** 1 0 0 0 0 6
NTb CA 2 1 1 1 1 1 0 0 0 1 1 0 0 0 2
HA 2 3 4 4 4 4 0 0 0 0 1 1 3 1 4
Total CA 29 23 22 23 24 23 8 14 4 11 19 9 7 4 37
HA 33 36 38 35 37 36 8 13 3 10 33 18 18 10 50
aRed and boldface indicates that there was a significant positive correlation between particular virulence gene and the serotype was found; blue and boldface indicates that there was
a significant negative correlation between particular virulence gene and the serotype was found. *p < 0.05, **p < 0.01, ***p < 0.001.
bNT, non-typeable.
cpsI and serotype III (CA and HA), between cpsG and serotype
III (CA and HA), between cpsF and serotype III (HA) (Table 3).
DISCUSSION
In our study, certain serotypes and clone types were significantly
associated with antibiotic resistance to drugs, such as
clindamycin or levofloxacin, and significant differences were
found in the resistance rates among the five serotypes in CA-GBS
and HA-GBS. There was good consistency of CA-GBS and
HA-GBS among STs, serotypes, and PFGE-based genotypes.
Furthermore, there were strong correlations of the CA- and/or
HA-serotypes with the genes encoding virulence proteins.
The most frequent STs were ST19, ST23, ST12, and ST1. ST19
had significantly different distributions in CA-GBS and HA-GBS
isolates, while other STs had similar distributions between these
groups. Previous work demonstrated that GBS strains of different
serotypes differ in their abilities to associate with host cells;
however, such studies selected strains on the basis of cps type
rather than ST (Korir et al., 2014). A very conserved and
consistent serotype distribution was observed among the GBS
isolates causing neonatal invasive disease in Europe, including
Portugal, Italy, Poland, and Greece, where capsular types Ia, V,
and III were predominant (Gherardi et al., 2007; Martins et al.,
2012; Liakopoulos et al., 2014; Romanik et al., 2014). However, in
the GBS isolates causing invasive disease in nonpregnant adults
in China, we observed that the dominant serotypes are noticeably
different from those found in these countries. Our data showed
that serotype III was the most prevalent in our study population
in China both in CA-GBS and HA-GBS, followed by serotypes
Ia, V, II, and Ib. These findings are similar to previous reports
(Ferrieri et al., 2013; Wang et al., 2013) from Europe, including
the United Kingdom, France, and Germany, and from North
America (Al et al., 2010; Ferrieri et al., 2013; Kulkarni et al., 2013;
Lamagni et al., 2013; Wang et al., 2013).
There was good consistency between certain STs and serotypes
in CA-GBS and HA-GBS isolates, such as ST19 and serotype
III, ST23 and serotype Ia, ST12 and serotype Ib, and ST1 and
serotype V, which agrees with the findings of previous reports
(Martins et al., 2012; Dutra et al., 2014). It has also been reported
(Wang et al., 2013) that ST19 is associated with serotypes Ib,
II, III, and IV, but we found mostly serotype III strains, along
with a few serotype V strains in our research, and this is likely
the reason that ST19 was mostly associated with serotype III
in our study. The isolates belonging to the same clonal groups
and/or serotypes were clustered in the same or approaching
PFGE clusters. Although the identification of various GBS strains
by PFGE provided high resolution, which may fully reflect the
gene polymorphisms of these strains, there was no significant
difference in the PFGE-based genotype distribution between
CA-GBS and HA-GBS isolates.
Penicillin was originally the first-line drug used in the
treatment and prophylaxis of GBS infections. The current
alternatives for patients allergic to penicillin include macrolides
and lincosamides (De Francesco et al., 2012). In our research
in Shanghai, rates of CA-GBS and HA-GBS resistance to
erythromycin, clindamycin, and levofloxacin were lower than
those reported in Beijing (Wang et al., 2013). The incidence
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of macrolide resistance is relatively low in western countries,
ranging from 14.5 to 32% (Gherardi et al., 2007; Phares et al.,
2008; Murayama et al., 2009; De Francesco et al., 2012; Lamagni
et al., 2013; Frohlicher et al., 2014). Although we are now more
and more seriously about the normalize use of antibiotics both
to outpatient and hospitalized patients, the high resistance was
associated with antibiotic misuse previously. Furthermore, in our
research, although there were no significant differences in the
rates of erythromycin, clindamycin, or levofloxacin resistance
between CA-GBS and HA-GBS isolates, HA-GBS MDR rate
was much higher than that of CA-GBS isolates, which creates
some difficulties during the clinical treatment of these infections
and suggests that patients with HA-GBS infection should be
considered different from patients with CA-GBS infection to
avoid treatment failure.
Previous work has indicated that serotype V and ST1 are
associated with erythromycin resistance (De Francesco et al.,
2012; Martins et al., 2012; Frohlicher et al., 2014). Most of the
CA- and HA-GBS isolates in our research showed high rates
of resistance to erythromycin, and the serotype and molecular
typing byMLST or PFGE showed that resistance to erythromycin
was associated with a variety of serotypes/clones, especially
serotype Ib/ST12. These findings indicate that both CA- and
HA-GBS isolates have a variety of phenotypic and genotypic
characteristics, and they suggest that macrolide-resistant isolates
may arise by clonal spread. Given that 0.7–10.0% of patients
are allergic to penicillin and that GBS strains have high rates of
resistance to erythromycin and clindamycin, fluoroquinolones
are a good alternative antibiotic for treating infections with GBS
(Wang et al., 2013). The rates of clindamycin and levofloxacin
resistance among the other four serotypes differed significantly
in CA- and HA-GBS, such as the rate of levofloxacin resistance
was significantly higher in serotype III isolates than in serotype
Ia, Ib, II, or V isolates. Therefore, serotype III was associated
with levofloxacin resistance. These findings are similar to
those of previous reports (Ueno et al., 2012; Wang et al.,
2013; Morozumi et al., 2014). Moreover, we found that ST19
(both CA-GBS and HA-GBS) was significantly associated with
levofloxacin resistance and the rate of clindamycin resistance
was significantly lower in CA- and HA-serotype Ia/ST23 than
in other serotypes/clonotypes, even though it was lowest in
serotypes II or Ib in other reports (Ueno et al., 2012; Wang
et al., 2013), which may be due to regional and/or population
differences between studies and as some serotypes have unique
epidemiological features that may lead to invasive diseases and
might occur in specific populations or geographic areas or be
associated with antibiotic resistance (Dutra et al., 2014). Our
research could provide a basis for using certain antibiotics against
particular serotypes or STs of CA-GBS and HA-GBS.
Invasion-related genes cylA and cylZ had significantly
different distributions in CA-GBS and HA-GBS isolates, while
adhesion and immune evasion-related genes had similar
distributions between these groups. The positive rates of
virulence genes fbsA, scpB, lmb, rib, bca, bac, and cfb were similar
to those reported by previous studies (Al et al., 2010, 2011; Udo
et al., 2013; Dutra et al., 2014; Korir et al., 2014) except for fbsB,
hylB, and spb1, which is likely due to the regional differences
between our study and theirs (Al et al., 2011; Udo et al., 2013;
Korir et al., 2014). Moreover, this study is the first to report the
positive rates of GBS virulence genes, such as GBS pilus cluster,
cyl operon, cps gene cluster, and neu gene cluster. In the last
decade, a pilus-like structure was identified in GBS and shown
to play an important role in the adhesion to and invasion of
host cells, in biofilm formation, and in resistance to phagocyte
killing (Firon et al., 2013). The β-hemolysin/cytolysin expressed
by GBS is an important virulence factor encoded within a cluster
of 12 genes forming the cyl operon, which is toxic to a broad
range of eukaryotic cells, resulting in cell invasion and evasion
of phagocytosis (Firon et al., 2013).
We also found a strong correlation of certain CA- and HA-
serotypes with the genes encoding virulence proteins, such as
between serotype Ib and bac, which was in agreement with the
previous reports (Martins et al., 2012). However, we also found
that of different findings, such as between serotypes V and rib,
which was reported that of between serotypes II and III and
rib (Martins et al., 2012). Moreover, we found that CA- and/or
HA-serotype III/ST19 isolates were significantly associated with
a few adhesion and immune evasion-related genes and that
adhesion-related genes (GBS pilus cluster) and invasion-related
genes (spb1) were expressed significantly less in CA- and
HA-serotype Ia/ST23 isolates than in other serotypes/clones.
A previous study reported that both ST17 and ST19 strains
were more often associated with invasive disease but that
ST23 strains were linked to asymptomatic colonization (Korir
et al., 2014), which may explain our findings in this study.
Certainly, not all isolates with particular serotypes and STs were
associated with these genes, and the identification of virulence
protein genes proved helpful in discriminating between different
genetic lineages within serotypes. These studies have furthered
appreciation of the roles that different serotypes and genotypes
expressing different virulence factors play in CA- and HA-
GBS diseases. Further research into these virulence genes may
aid in the future development of new vaccines to reduce GBS
infections.
There were still some limitations of the methods in our
research. One was the limit number of the non-repetitive
strains, which was not a large one and might lead to some
statistical constraints although we had already made the
adjustment to controlling for a false-discovery rate (FDR). The
other was the limited reagent kit to identify GBS serotype,
which was capable of only six serotypes including Ia, Ib,
II, III, IV, and V, therefore uncovered serotypes could be
think as NT.
In summary, CA-GBS and HA-GBS isolates had significantly
similar correlations among STs, clonal clusters, PFGE
types, serotypes, and virulence genes, but also had some
differences in distribution of clonal, serotypes, virulence
genes, and antimicrobial resistance, which show the molecular
characterization.Most previous studies have focused onmaternal
and neonatal GBS infections; to our knowledge, our study is
the first to report the GBS infection status of nonpregnant
adults in China and is also the first to compare the molecular
characteristics of HA-GBS and CA-GBS infection. In the near
future, additional GBS strains should be collected from areas
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throughout China and further epidemiological data should
be analyzed and compared, leading to a more comprehensive
data analysis of the infection of clinically important strains.
Further research on specific drug-resistant clones and the
regulation of virulence genes is also needed to provide a
basis for infection control and more reliable target for the
development of new vaccines for the prevention of GBS invasive
infections.
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